Computational oncology — mathematical modelling of drug regimens for precision medicine

被引:0
|
作者
Dominique Barbolosi
Joseph Ciccolini
Bruno Lacarelle
Fabrice Barlési
Nicolas André
机构
[1] SMARTc Unit,Department of Paediatric Haematology and Oncology
[2] Aix Marseille Université,undefined
[3] INSERM,undefined
[4] Aix Marseille Université,undefined
[5] INSERM,undefined
[6] Multidisciplinary Oncology Unit,undefined
[7] Nord University Hospital of Marseille,undefined
[8] Assistance Publique - Hôpitaux de Marseille (AP-HM),undefined
[9] Hospital of La Timone,undefined
[10] AP-HM,undefined
[11] Centre d'Essais Précoce Cancérologie Marseille (CEPCM),undefined
[12] Hospital of La Timone,undefined
[13] AP-HM,undefined
来源
Nature Reviews Clinical Oncology | 2016年 / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
With the ever-increasing processing power of new computer hardware and software, the mathematical sciences are constantly advancing and the use of mathematical models in medicine is expandingTo date, computational oncology has been implemented mostly in systems-biology studies as a means to better understand cancer biologyComputation oncology can be applied to refine drug dosing and scheduling, which could benefit from sophisticated modelling of pharmacokinetics (PK)/pharmacodynamics (PD) relationships and the formulation of innovative clinical trial designsMathematical strategies can be used to predict tumour responses, efficacy, and toxicity during treatment planning or adaptationProvision of personalized medicine could be improved through systems-biology approaches that incorporate both multiscale modelling and PK/PD modelling to ensure a better efficacy–toxicity balance of treatmentThe use of dedicated models to rationally design drug regimens in oncology should result in improved efficacy of treatment and decreased toxicity
引用
收藏
页码:242 / 254
页数:12
相关论文
共 50 条
  • [1] Computational oncology - mathematical modelling of drug regimens for precision medicine
    Barbolosi, Dominique
    Ciccolini, Joseph
    Lacarelle, Bruno
    Barlesi, Fabrice
    Andre, Nicolas
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (04) : 242 - 254
  • [2] Clinical Computational Oncology for Precision Cancer Medicine.
    Wallace, S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2019, 60 : 22 - 23
  • [3] Precision medicine in oncology drug development: a pharma perspective
    Hollingsworth, Simon J.
    DRUG DISCOVERY TODAY, 2015, 20 (12) : 1455 - 1463
  • [4] Precision Medicine: Getting Oncology Drug Development Right
    Bennett C.
    Genetic Engineering and Biotechnology News, 2019, 39 (01): : 82
  • [5] Accelerating precision cancer medicine through clinical computational oncology
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2017, 77 (22)
  • [6] Computational Studies on Antibody Drug Conjugates (ADCs) for Precision Oncology
    Srivastava, Ruby
    CHEMISTRYSELECT, 2022, 7 (34):
  • [7] Editorial: Computational Approaches in Drug Discovery and Precision Medicine
    Huang, Zunnan
    Yao, Xiao Jun
    Gu, Ruo-Xu
    FRONTIERS IN CHEMISTRY, 2021, 8
  • [8] Precision medicine-based drug treatment individualization in oncology
    Martin, Jennifer H.
    Olver, Ian
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (02) : 223 - 226
  • [9] Precision medicine in oncology
    Mack, Elisabeth
    INNERE MEDIZIN, 2024, 65 (03): : 194 - 201
  • [10] Precision medicine in oncology
    Takebe, Naoko
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (03) : 163 - 165